Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 8, 1996, Pages 681-689

  Nyyssonen K ^a   Kaikkonen, J ^a   Salonen, J T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chromatography; Glutathione; LDL cholesteroI; Modified LDL; n 3 polyunsaturated fatty acid; Oxidation; carotene

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; GLUTATHIONE DISULFIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

ADULT; AGED; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; TECHNIQUE;

ORYCTOLAGUS CUNICULUS;

EID: 0030513702     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088815     Document Type: Article

References (23)

1. Steinberg D. and Workshop Participants. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2337-44.
2. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-4.
3. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-5.
4. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-7.
5. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, et al. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994; 14: 1892-9.
6. Cazzolato G, Avogaro P, Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Rad Biol Med 1991; 11: 247-53.
7. Vedie BI, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, et al. Fractionation of charge-modified low-density lipoproteins by fast protein liquid chromatography. J Lipid Res 1991; 32: 1359-69.
8. Nyyssönen K, Salonen JT. Comparison of gel permeation chromatography, density gradient ultracentrifugation and precipitation methods for quantitation of very-low, low- and high-density lipoprotein cholesterol. J Chromatogr 1991; 570: 382-9.
9. Baker MA, Cerniglia JC, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360-5.
10. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatogaphic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988; 34: 377-81.
11. Nyyssönen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 1994; 48: 633-42.
12. Parviainen MT, Nyyssönen K, Penttilä IM, Seppänen K, Rauramaa R, Salonen JT, et al. A method for routine assay of plasma ascorbic acid using high-performance liquid chromatography. J Liq Chromatogr 1986; 9: 2185-97.
13. Berliner JA, Territo MC, Sevanian A, Ramin S, Ai Kim J, Bamshad B, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1991; 85: 1260-6.
14. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, et al. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 1991; 87: 2253-7.
15. Mahley RW, Innerarity TL, Weisgraber KH, Oh SY. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J Clin Invest 1979; 64: 743-50.
16. Fogelman AM, Sechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoprotein leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980; 77: 2214-18.
17. Bittolo Bon G, Cazzolato G, Avogaro P. Does a circulating oxidized LDL exist and can it be detected? In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, editors, Free radicals, lipoprotein oxidation and atherosclerosis: biological and clinical aspects, London: Richelieu Press, 1995: 205-28.
18. Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79-87.
19. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parathasarathy S, Carew TE, Butler S, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989: 84: 1086-95.
20. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54: 1969-75.
21. Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991; 87: 597-601.
22. De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298-306.
23. Demuth K, Myara I, Chappey B, Vedie B, Pech-Amsellem MA, Haberland ME, et al. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscl Thromb Vasc Biol 1996; 16: 773-83.